Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy

You Ke,1 Cheng Xiang2 1Department of Nephrology, The Second Affiliated Hospital of Zhejiang University, Hangzhou, China; 2Department of Surgery, The Second Affiliated Hospital of Zhejiang University, Hangzhou, China Background: Thyroid cancer becomes the most common endocrine cancer with the great...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ke Y, Xiang C
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/982fc76b45f340d6a995fcae8a006fdd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!